Mirum Pharmaceuticals, Inc.
MIRM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001759425
In the last 90 days, Mirum Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 10 sales; 326 institutions reported holding it in 13F filings for Q2 2026, worth $8.36B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Mirum Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 110
- +13 vs. Q1 2022
- Shares held
- 29.3M
- +2.53M (+9.5%) vs. Q1 2022
- Total value
- $569.4M
- −$20.6M (−3.5%) vs. Q1 2022
- New holders
- 24
- 47 more added
- Sold out
- 11
- 22 more reduced
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIRM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 326 | $8.36B |
| Q1 2026 | 311 | $6.29B |
| Q4 2025 | 284 | $4.82B |
| Q3 2025 | 272 | $4.20B |
| Q2 2025 | 214 | $2.82B |
| Q1 2025 | 214 | $2.44B |
| Q4 2024 | 205 | $2.19B |
| Q3 2024 | 178 | $2.08B |
| Q2 2024 | 161 | $1.83B |
| Q1 2024 | 172 | $1.34B |
| Q4 2023 | 187 | $1.48B |
| Q3 2023 | 159 | $1.55B |
| Q2 2023 | 146 | $955.6M |
| Q1 2023 | 117 | $832.9M |
| Q4 2022 | 104 | $650.2M |
| Q3 2022 | 112 | $709.1M |
| Q2 2022 | 110 | $569.4M |
| Q1 2022 | 99 | $590.4M |
| Q4 2021 | 86 | $395.7M |
| Q3 2021 | 73 | $465.0M |
| Q2 2021 | 67 | $404.6M |
| Q1 2021 | 61 | $463.3M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Mirum Pharmaceuticals, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Polar Capital Holdings Plc | 1,212,432 | $23.6M | 0.18% | +238,723+24.5% | Added |
| Franklin Resources Inc | 1,249,122 | $24.3M | 0.01% | +5780.0% | Added |
| Cadian Capital Management, LP | 1,385,997 | $27.0M | 1.82% | +640,997+86.0% | Added |
| BlackRock Inc. | 1,396,012 | $27.2M | 0.00% | +613,182+78.3% | Added |
| Rock Springs Capital Management LP | 1,717,733 | $33.4M | 0.97% | +51,525+3.1% | Added |
| RiverVest Venture Management LLC | 1,921,118 | $37.4M | 54.94% | 00.0% | Unchanged |
| Novo Holdings A/S | 2,027,324 | $37.9M | 1.87% | −172,676−7.8% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 3,244,434 | $63.1M | 1.33% | −38,478−1.2% | Reduced |
| Frazier Life Sciences Management, L.P. | 3,566,912 | $69.4M | 6.55% | 00.0% | Unchanged |
| NEA Management Company, LLC | 4,187,801 | $81.5M | 4.19% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −161,285−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −153,389−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −43,908−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −23,115−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −21,691−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −15,848−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −14,869−100.0% | Sold out |
| AdvisorShares Investments LLC | 0 | $0 | 0.00% | −13,100−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −10,958−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,774−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −364−100.0% | Sold out |
| Golden State Equity Partners | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |